Skip to main content

Table 6 The IC50 value of different drug formulations in HT-29 cells at 48 and 72 h

From: Efficient targeting of HIF-1α mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy

Time (hours)

IC50(µg/ml)

YC-1

PX-12

YC/PX

NIO/YC-PX

Blank niosome

48

25

52.134

24.36

75.13

934.65

72

23.78

27.54

22.65

16.32

789.64